Non-Prescribed Substance Use during the First Month of Treatment by People Receiving Depot Buprenorphine for Opioid Use Disorder-Reference-Cited by-同舟云学术

Non-Prescribed Substance Use during the First Month of Treatment by People Receiving Depot Buprenorphine for Opioid Use Disorder

Published:2023-08-12 Issue:13 Volume:58 Page:1696-1706
ISSN:1082-6084
Container-title:Substance Use & Misuse
language:en
Short-container-title:Substance Use & Misuse

Author:

Parkin Stephen¹,Neale Joanne¹²,Strang John¹³

Affiliation:

1. Institute of Psychiatry, National Addiction Centre, King’s College London, London, UK

2. Centre for Social Research in Health, University of New South Wales, Kensington, Australia

3. South London & Maudsley (SLaM), NHS Foundation Trust, London, UK

Funder

Camurus AB

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Medicine (miscellaneous),Health (social science)

Link

https://www.tandfonline.com/doi/pdf/10.1080/10826084.2023.2244064

Reference42 articles.

1. Retention rates with monthly depot buprenorphine in general practice in Melbourne, Australia

2. Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients’ experiences in Australia

3. Medication Treatment of Opioid Use Disorder

4. ‘Topping up’ methadone: An analysis of patterns of heroin use among a treatment sample of Scottish drug users

5. Breen P. & Butt A. (2022). Deaths related to drug poisoning in England and Wales: 2021 registrations. Office for National Statistics Statistical Bulletin 03 August 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsrelatedtodrugpoisoninginenglandandwales/2021registrations

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in polysubstance use among patients in methadone maintenance treatment in Ireland: Evidence from urine drug testing 2010–2020;Journal of Substance Use and Addiction Treatment;2024-12

2. Long-Acting Injectable Buprenorphine for Opioid Use Disorder: A Qualitative Analysis of Patients’ Interpersonal Relationships during the First Year of Treatment;Substance Use & Misuse;2024-08-20

3. ‘Matters-of-concern’ associated with discontinuation of long-acting injectable buprenorphine: Findings from a longitudinal qualitative study;International Journal of Drug Policy;2024-07

4. Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey: Findings from a longitudinal qualitative study;International Journal of Drug Policy;2023-12